Phase 2 DESTINY-Gastric01 Trial of DS-8201 Versus Chemotherapy Met Primary Endpoint

Trial met primary endpoint of objective response rate and key secondary endpoint of overall survival in patients with previously treated HER2 positive metastatic gastric cancer TOKYO, MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced positive topline results from the pivotal phase 2 DESTINY-Gastric01 trial of DS-8201, a … [Read more…]

Genentech Submits Supplemental Biologics License Application to the FDA for Tecentriq in Combination With Avastin for the Most Common Form of Liver Cancer

– Application is being reviewed under FDA’s Real-Time Oncology Review pilot program – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the completion of a supplemental Biologics License Application (sBLA) submission to the U.S. Food and Drug Administration (FDA) for Tecentriq® (atezolizumab) in combination with … [Read more…]

Omnicell Showcases Latest Advancements to Medication Management Portfolio at Arab Health Exhibition and Congress

New Technologies Target Zero Error, Fully Automated Medication Management MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced the Company will be showcasing the latest advancements to its medication management portfolio at the Arab Health Exhibition and Congress from 27-30 January … [Read more…]

Data from NantHealth’s GPS Cancer platform reveals increased opportunities for HER2 directed therapy in colorectal cancer patients

NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium SAN FRANCISCO–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced Results of a fifty-gene breast cancer RNA subtype classifier applied to 167 colorectal cancer (CRC) patients during a poster session at the 2020 Gastrointestinal Cancer Symposium sponsored by the American … [Read more…]

NantHealth’s Eviti Connect Data Shows Recycling of Chemotherapy and Biologics for Advanced CRC Patients More Common Than Switching to Drug Regimens with Alternative Mechanism of Action

NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium SAN FRANCISCO–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced new real-world data on treatment patterns for patients with advanced colorectal cancer (CRC) during a poster session at the 2020 Gastrointestinal Cancer Symposium sponsored by the American Society of Clinical … [Read more…]

Horizon Therapeutics plc Announces Changes in Research and Development Organization

– Scott Brun, M.D. Named Senior R&D Advisor – DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced changes to its research and development organization structure. Effective immediately, Elizabeth H.Z. Thompson, Ph.D., group vice president, clinical development and external search; Srini Ramanathan, Ph.D., group vice president, development sciences and San Francisco site head and Melanie Gloria, … [Read more…]

DeciBio Spins off Technology Products as a Subsidiary Entity, DeciBio Analytics

LOS ANGELES–(BUSINESS WIRE)–#bigdata–Last year, DeciBio Consulting announced the formation of DeciBio Analytics, a subsidiary entity that develops market intelligence informatics tools and technologies and informatics-oriented consulting work. With the mission to accelerate commercialization of innovation in the precision medicine space by building novel and propriety solutions that empower our clients, DeciBio Analytics will continue to … [Read more…]

Gloo personal growth platform powers new research partnership with Behavioral Health Learning Network

BOULDER, Colo.–(BUSINESS WIRE)–Gloo, LLC, a trusted technology platform provider for organizations that champion personal growth, announced today that it is partnering with the Psychiatry and Behavioral Health Learning Network (PBHLN) to power a virtual center of excellence aimed at improving patient outcomes among the nation’s mental health treatment and addiction recovery providers. HMP Global, a … [Read more…]

China SXT Pharmaceuticals, Inc. Announces Plans to Increase Production

TAIZHOU, China–(BUSINESS WIRE)–China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), announced today that it will be increasing its production of its entire TCM product line, in response to recent Chinese government pronouncements signaling … [Read more…]

The Behavioral Health Provider Network Kicks Off 2-Day Continuing Education Conference Today

The Enhancing Your Impact conference brought to BHPN providers at no cost focuses on advancing the practice of behavioral health and evidence-based treatment throughout Northern California WALNUT CREEK, Calif.–(BUSINESS WIRE)–The Behavioral Health Provider Network (BHPN), a non-profit organization headquartered in Walnut Creek, is hosting its first annual conference for continuing education, Enhancing Your Impact, in … [Read more…]